Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
0.63%0.71%16.14x1.88x3.5x9.43x10.33x 63.43B
0.57%0.59%27.43x4.13x5.57x16.28x20.28x 55.14B
-.--%-.--%34.24x6.9x11.59x21.87x25.89x 41.58B
3.59%3.7%-51.08x2.33x3.04x8.99x10.49x 37.99B
-.--%-.--%32.23x1.59x3.47x10.65x12.39x 29.47B
-.--%-.--%-6.99x4.12x9.78x-5.96x-5.65x 23.97B
-.--%-.--%16.16x3.22x2.97x9.17x9.05x 21.67B
-.--%0.06%49.16x4.97x5.39x37.35x34.51x 17.28B
-.--%-.--%26.1x3.68x5.41x14.54x20.2x 16.7B
-.--%-.--%-31.88x-5.53x14.86x-45.2x-46.98x 13.58B
0.14%0.14%67.97x27.72x41.39x58.53x60.37x 12.91B
-.--%-.--%-120.71x12601.69x12.31x-109.08x-119.86x 12.24B
-.--%-.--%16.28x - 3.49x12.78x15.32x 11.08B
-.--%-.--%45.09x - - - - 10.25B
2.84%3.28%11.82x1.03x1.8x7.28x9.75x 6.17B
1.72%1.91%13.02x1.2x2.21x5.79x6.92x 5.24B
-.--%-.--%-104.1x - - - - 5.09B
Average 0.56% 0.61% 2.40x 904.21x 8.45x 3.49x 4.20x 22.58B
Weighted average by Cap. 0.62% 0.65% 9.53x 435.59x 7.22x 8.22x 9.63x
Biopharmaceuticals